{"organizations": [], "uuid": "cbc68407c0527ccd1120c109096e3d6e9f08c0fe", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180509.html", "section_title": "Archive News &amp; Video for Wednesday, 09 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-idera-pharmaceuticals-reports-q1-l/brief-idera-pharmaceuticals-reports-q1-loss-per-share-0-10-idUSASC0A0WG", "country": "US", "domain_rank": 408, "title": "BRIEF-Idera Pharmaceuticals Reports Q1 Loss Per Share $0.10", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.016, "site_type": "news", "published": "2018-05-09T19:12:00.000+03:00", "replies_count": 0, "uuid": "cbc68407c0527ccd1120c109096e3d6e9f08c0fe"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-idera-pharmaceuticals-reports-q1-l/brief-idera-pharmaceuticals-reports-q1-loss-per-share-0-10-idUSASC0A0WG", "ord_in_thread": 0, "title": "BRIEF-Idera Pharmaceuticals Reports Q1 Loss Per Share $0.10", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "idera pharmaceuticals inc", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 9 (Reuters) - Idera Pharmaceuticals Inc:\n* IDERA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE\n* Q1 LOSS PER SHARE $0.10 * Q1 EARNINGS PER SHARE VIEW $-0.09 â€” THOMSON REUTERS I/B/E/S\n* AS OF MARCH 31, 2018, CASH AND CASH EQUIVALENTS TOTALED $107.5 MILLION COMPARED TO $112.6 MILLION AS OF DECEMBER 31, 2017\n* SEES EXISTING CASH, CASH EQUIVALENTS AND INVESTMENTS WILL FUND OPERATIONS INTO Q3 OF 2019 Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-09T19:12:00.000+03:00", "crawled": "2018-05-10T17:48:51.037+03:00", "highlightTitle": ""}